Immunosuppressive therapy with rituximab in common variable immunodeficiency-Reference-Cited by-同舟云学术

Immunosuppressive therapy with rituximab in common variable immunodeficiency

Published:2019-05-06 Issue:1 Volume:17 Page:
ISSN:1476-7961
Container-title:Clinical and Molecular Allergy
language:en
Short-container-title:Clin Mol Allergy

Author:

Pecoraro Antonio,Crescenzi Ludovica,Galdiero Maria Rosaria,Marone Giancarlo,Rivellese Felice,Rossi Francesca Wanda,de Paulis Amato,Genovese Arturo,Spadaro Giuseppe^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s12948-019-0113-3.pdf

Reference123 articles.

1. Feugier P. A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin’s lymphomas. Future Oncol. 2015;11(9):1327–42. https://doi.org/10.2217/fon.15.5 .

2. Du J, Wang H, Zhong C, Peng B, Zhang M, Li B, Huo S, Guo Y, Ding J. Structural basis for recognition of CD20 by therapeutic antibody rituximab. J Biol Chem. 2007;282(20):15073–80.

3. Musette P, Bouaziz JD. B cell modulation strategies in autoimmune diseases: new concepts. Front Immunol. 2018;9:622. https://doi.org/10.3389/fimmu.2018.00622 .

4. Oldham RJ, Cleary KLS, Cragg MS. CD20 and its antibodies: past, present, and future. Forum Immunopathol Dis Ther. 2014;5(1–2):7–23. https://doi.org/10.1615/ForumImmunDisTher.2015014073 .

5. Marshall MJE, Stopforth RJ, Cragg MS. Therapeutic antibodies: what have we learnt from targeting CD20 and where are we going? Front Immunol. 2017;8:1245. https://doi.org/10.3389/fimmu.2017.01245 .

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The common variable immunodeficiency IgM repertoire narrowly recognizes erythrocyte and platelet glycans;Journal of Allergy and Clinical Immunology;2024-09

2. The Immune System and Hematopoietic Stem Cells;Comprehensive Hematology and Stem Cell Research;2024

3. Rituximab and improved nodular regenerative hyperplasia-associated non-cirrhotic liver disease in common variable immunodeficiency: a case report and literature study;Frontiers in Immunology;2023-09-19

4. Immune tolerance breakdown in inborn errors of immunity: Paving the way to novel therapeutic approaches;Clinical Immunology;2023-06

5. Is there a role for microbiome-based approach in common variable immunodeficiency?;Clinical and Experimental Medicine;2023-02-03